Apply Now - Doctoral Candidate 10 - Gothenburg University, Sweden

This PhD study will focus on microbiological and molecular profiling of human biosamples, obtained from the largest clinical cohort study on hearing implants, will be conducted to identify biomarkers linked to tissue complications. Biomarkers will be identified and paired with clinical measures to improve diagnostic accuracy and personalised patient care. The PhD student will also evaluate the cytocompatibility and antimicrobial efficacy of implant surfaces functionalised with antimicrobial peptides (AMPs) using experimental infection models to assess the biocompatibility and therapeutic potential of AMP-coated titanium and polymers in controlling infection and promoting tissue integration.  

APPLY HERE: link to Gothenburg University, Sweden - Application Deadline: 24 Oct 2025 - 00:00 (Europe/Stockholm)

• Learn more about this position at EURAWESS: Doctoral Candidate (PhD student position in Medical Science - Biomaterials with a focus on infection microbiology) at University of Gothenburg, Sweden / DC10 - SHIELD Doctoral Network.
• Host institution: GÖTEBORGS UNIVERSITET (UGOT), Sweden
• Research group website: Biomaterials, Orthopaedics, Infectious diseases
• Supervisor: M. Trobos, e-mail: margarita.trobos@biomaterials.gu.se
• More information at SHIELD's web page about Research Project 10

Training and mobility:

• Research secondments at SHIELD partner institutions:
  • The University of Birmingham (United Kingdom)
  • The Chancellor Masters and Scholars of The University of Cambridge (United Kingdom)
  • Amicoat AS (Norway)
• Participation in specialised training workshops and international conferences.

This PhD position is part of the European Doctoral Network “SHIELD” (Strategies for Healing Implant-associated infections and Enhancing Longevity in Devices), led by the University of Gothenburg. 

SHIELD offers an exciting opportunity for 16 early-career researchers to contribute to transforming the management of infections associated with medical implants. Focused on addressing the challenges posed by implant-associated infections (IAIs), SHIELD aims to deepen our understanding of IAI mechanisms and develop innovative antibacterial biomaterials to improve patient outcomes.